Cargando…

Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo

OBJECTIVE: Angiotensin (ANG) II interacts with insulin-signaling pathways to regulate insulin sensitivity. The type 1 (AT(1)R) and type 2 (AT(2)R) receptors reciprocally regulate basal perfusion of muscle microvasculature. Unopposed AT(2)R activity increases muscle microvascular blood volume (MBV) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Weidong, Wang, Wenhui, Dong, Zhenhua, Cao, Wenhong, Liu, Zhenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198098/
https://www.ncbi.nlm.nih.gov/pubmed/21896931
http://dx.doi.org/10.2337/db10-1691
_version_ 1782214382762065920
author Chai, Weidong
Wang, Wenhui
Dong, Zhenhua
Cao, Wenhong
Liu, Zhenqi
author_facet Chai, Weidong
Wang, Wenhui
Dong, Zhenhua
Cao, Wenhong
Liu, Zhenqi
author_sort Chai, Weidong
collection PubMed
description OBJECTIVE: Angiotensin (ANG) II interacts with insulin-signaling pathways to regulate insulin sensitivity. The type 1 (AT(1)R) and type 2 (AT(2)R) receptors reciprocally regulate basal perfusion of muscle microvasculature. Unopposed AT(2)R activity increases muscle microvascular blood volume (MBV) and glucose extraction, whereas unopposed AT(1)R activity decreases both. The current study examined whether ANG II receptors modulate muscle insulin delivery and sensitivity. RESEARCH DESIGN AND METHODS: Overnight-fasted rats were studied. In protocol 1, rats received a 2-h infusion of saline, insulin (3 mU/kg/min), insulin plus PD123319 (AT(2)R blocker), or insulin plus losartan (AT(1)R blocker, intravenously). Muscle MBV, microvascular flow velocity, and microvascular blood flow (MBF) were determined. In protocol 2, rats received (125)I-insulin with or without PD123319, and muscle insulin uptake was determined. RESULTS: Insulin significantly increased muscle MBV and MBF. AT(2)R blockade abolished insulin-mediated increases in muscle MBV and MBF and decreased insulin-stimulated glucose disposal by ~30%. In contrast, losartan plus insulin increased muscle MBV by two- to threefold without further increasing insulin-stimulated glucose disposal. Plasma nitric oxide increased by >50% with insulin and insulin plus losartan but not with insulin plus PD123319. PD123319 markedly decreased muscle insulin uptake and insulin-stimulated Akt phosphorylation. CONCLUSIONS: We conclude that both AT(1)Rs and AT(2)Rs regulate insulin’s microvascular and metabolic action in muscle. Although AT(1)R activity restrains muscle metabolic responses to insulin via decreased microvascular recruitment and insulin delivery, AT(2)R activity is required for normal microvascular responses to insulin. Thus, pharmacologic manipulation aimed at increasing the AT(2)R-to-AT(1)R activity ratio may afford the potential to improve muscle insulin sensitivity and glucose metabolism.
format Online
Article
Text
id pubmed-3198098
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31980982012-11-01 Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo Chai, Weidong Wang, Wenhui Dong, Zhenhua Cao, Wenhong Liu, Zhenqi Diabetes Pathophysiology OBJECTIVE: Angiotensin (ANG) II interacts with insulin-signaling pathways to regulate insulin sensitivity. The type 1 (AT(1)R) and type 2 (AT(2)R) receptors reciprocally regulate basal perfusion of muscle microvasculature. Unopposed AT(2)R activity increases muscle microvascular blood volume (MBV) and glucose extraction, whereas unopposed AT(1)R activity decreases both. The current study examined whether ANG II receptors modulate muscle insulin delivery and sensitivity. RESEARCH DESIGN AND METHODS: Overnight-fasted rats were studied. In protocol 1, rats received a 2-h infusion of saline, insulin (3 mU/kg/min), insulin plus PD123319 (AT(2)R blocker), or insulin plus losartan (AT(1)R blocker, intravenously). Muscle MBV, microvascular flow velocity, and microvascular blood flow (MBF) were determined. In protocol 2, rats received (125)I-insulin with or without PD123319, and muscle insulin uptake was determined. RESULTS: Insulin significantly increased muscle MBV and MBF. AT(2)R blockade abolished insulin-mediated increases in muscle MBV and MBF and decreased insulin-stimulated glucose disposal by ~30%. In contrast, losartan plus insulin increased muscle MBV by two- to threefold without further increasing insulin-stimulated glucose disposal. Plasma nitric oxide increased by >50% with insulin and insulin plus losartan but not with insulin plus PD123319. PD123319 markedly decreased muscle insulin uptake and insulin-stimulated Akt phosphorylation. CONCLUSIONS: We conclude that both AT(1)Rs and AT(2)Rs regulate insulin’s microvascular and metabolic action in muscle. Although AT(1)R activity restrains muscle metabolic responses to insulin via decreased microvascular recruitment and insulin delivery, AT(2)R activity is required for normal microvascular responses to insulin. Thus, pharmacologic manipulation aimed at increasing the AT(2)R-to-AT(1)R activity ratio may afford the potential to improve muscle insulin sensitivity and glucose metabolism. American Diabetes Association 2011-11 2011-10-17 /pmc/articles/PMC3198098/ /pubmed/21896931 http://dx.doi.org/10.2337/db10-1691 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Pathophysiology
Chai, Weidong
Wang, Wenhui
Dong, Zhenhua
Cao, Wenhong
Liu, Zhenqi
Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title_full Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title_fullStr Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title_full_unstemmed Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title_short Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo
title_sort angiotensin ii receptors modulate muscle microvascular and metabolic responses to insulin in vivo
topic Pathophysiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198098/
https://www.ncbi.nlm.nih.gov/pubmed/21896931
http://dx.doi.org/10.2337/db10-1691
work_keys_str_mv AT chaiweidong angiotensiniireceptorsmodulatemusclemicrovascularandmetabolicresponsestoinsulininvivo
AT wangwenhui angiotensiniireceptorsmodulatemusclemicrovascularandmetabolicresponsestoinsulininvivo
AT dongzhenhua angiotensiniireceptorsmodulatemusclemicrovascularandmetabolicresponsestoinsulininvivo
AT caowenhong angiotensiniireceptorsmodulatemusclemicrovascularandmetabolicresponsestoinsulininvivo
AT liuzhenqi angiotensiniireceptorsmodulatemusclemicrovascularandmetabolicresponsestoinsulininvivo